STOCK TITAN

EAGLE PHARMS INC (EGRX) Net Income by Year

EGRX

EAGLE PHARMS INC reported $35.6M in net income in fiscal year 2022. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2022 through Q2 FY2023, the same line adds up to $11.9M in net income. The table below carries 11 fiscal years, from 2012 to 2022, and the quarters EAGLE PHARMS INC has filed alongside them.

FY2022 annual
Net Income $35.6M
YoY n/m
5Y CAGR -7.3%
10Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2023, ended Jun 30, 2023 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

EGRX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Net Income$11.9M$35.6Mn/m-$8.6M-172.0%$12.0M-16.2%$14.3M-55.1%$31.9M-38.6%$51.9M-36.2%$81.5M+3068.1%$2.6Mn/m-$18.0Mn/m-$6.0Mn/m-$19.4M

TTM is the trailing twelve months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.

EGRX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-QQ4'2110-KQ3'2110-QQ2'2110-QQ1'2110-QQ4'2010-KQ3'2010-Q
Net Income$5.2Mn/m$5.8M-86.9%$8.2Mn/m-$7.1Mn/m-$9.4M-361.6%$44.1Mn/m-$6.2M-176.9%-$5.6M-179.6%$3.6Mn/m-$421Kn/m$8.1M$7.1Mn/m

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More EAGLE PHARMS INC financials

Frequently Asked Questions

What was EAGLE PHARMS INC's net income in fiscal year 2022?

EAGLE PHARMS INC reported $35.6M in net income in fiscal year 2022.

How fast is EAGLE PHARMS INC's net income growing?

EAGLE PHARMS INC (EGRX) reported a $8.6M net loss in fiscal year 2021 and $35.6M in net income in fiscal year 2022. A growth rate is not meaningful here, because the earlier figure was zero or negative.

What is EAGLE PHARMS INC's net income over the last twelve months?

EAGLE PHARMS INC (EGRX) reported $11.9M in net income over the trailing 12 months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.

Across the 11 fiscal years this page covers, EAGLE PHARMS INC (EGRX) net income went from -$19.4M in fiscal year 2012 to $35.6M in fiscal year 2022.

EAGLE PHARMS INC (EGRX) reported $5.2M in net income in Q2 2023. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what EAGLE PHARMS INC (EGRX) reported on that line in every period on record.